Human induced pluripotent stem cells (iPSCs) have a great potential for scientific and medical applications. They are used in ...

In a significant stride for the global regenerative medicine industry, MetaTech Inc., a leading biotechnology company in ...

Researchers led by Osaka University in Japan have conducted the first human trial using induced pluripotent stem-cell-derived ...

Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) ...

Multiplexed-engineered, iPSC-derived CAR T Cell Targets Proteins Expressed on Cancer Cells in Response to Cellular Stress and Malignant ...

A revolutionary stem cell treatment restored the vision of three people by repairing their damaged corneas. Initially, four ...

In a medical breakthrough, three people with severely impaired vision who received stem-cell transplants two years ago have ...

Analysis By Type, By Stem Cell Source, By Application, By End User, By Region Size and Trends Forecast up to 2029" report has ...

The following is a summary of “Patient iPSC-derived neural progenitor cells display aberrant cell cycle control, p53, and DNA ...

撰文丨王聪编辑丨王多鱼排版丨水成文嵌合抗原受体T细胞疗法（CAR-T细胞疗法）的出现，是近年来癌症免疫治疗领域的一大突破，自2017年以来，美国FDA已经批准了6款CAR-T细胞疗法上市，用于治疗白血病、淋巴瘤等血液类癌症，展现了让人印象深刻的强大效 ...